Jun 17, 2026 08:03AM
Jun 17, 2026 08:00AM
Jun 16, 2026 05:28PM
Jun 4, 2026 04:05PM
May 27, 2026 04:30PM
May 13, 2026 08:30AM
May 6, 2026 08:02AM Azitra receives US patent for ATR-12 Netherton syndrome treatment
May 6, 2026 08:00AM
Apr 28, 2026 08:02AM
Mar 19, 2026 01:14PM
Mar 19, 2026 01:13PM
Mar 13, 2026 05:16PM
Mar 13, 2026 05:15PM
Mar 5, 2026 04:30PM Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders
Feb 27, 2026 05:30PM
Feb 24, 2026 08:00AM
Feb 19, 2026 08:00AM
Feb 6, 2026 04:15PM
Dec 17, 2025 04:10PM
Dec 17, 2025 04:10PM
Nov 12, 2025 05:15PM Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates
Nov 7, 2025 06:00AM
Nov 7, 2025 06:00AM
Oct 20, 2025 08:02AM
Oct 20, 2025 08:02AM
Oct 15, 2025 04:05PM
Oct 3, 2025 04:45PM
Oct 3, 2025 04:45PM Azitra Receives Notice of Non-Compliance from NYSE American
Sep 4, 2025 08:10AM
Aug 27, 2025 08:10AM
Aug 27, 2025 08:10AM
Aug 11, 2025 04:15PM
Aug 11, 2025 04:15PM
Jun 17, 2025 08:02AM
Jun 17, 2025 08:02AM Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome
Jun 10, 2025 08:33AM
May 28, 2025 08:33AM
May 14, 2025 04:05PM
May 13, 2025 05:06PM
Apr 25, 2025 08:33AM
Apr 24, 2025 04:06PM
Apr 24, 2025 04:05PM Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline
Mar 12, 2025 08:33AM
Feb 24, 2025 08:30AM
Feb 4, 2025 02:20PM
Feb 4, 2025 02:20PM
Feb 3, 2025 09:05AM
Jan 27, 2025 04:05PM
Jan 15, 2025 08:30AM Azitra, Inc (AZTR) Prices 4.86M Share Offering at $0.30/sh
Jan 15, 2025 08:30AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All